Published in Healthc Inform on April 01, 2011
The parathyroid is a target organ for FGF23 in rats. J Clin Invest (2007) 4.47
Lanthanum carbonate decreases PTH gene expression with no hepatotoxicity in uraemic rats. Nephrol Dial Transplant (2006) 2.20
PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop. Am J Physiol Renal Physiol (2010) 2.19
Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int (2009) 2.09
A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis. J Clin Endocrinol Metab (2005) 1.56
Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: correlation with posttranslational modification of the trans acting factor AUF1. J Am Soc Nephrol (2005) 1.09
The peptidyl-prolyl isomerase Pin1 determines parathyroid hormone mRNA levels and stability in rat models of secondary hyperparathyroidism. J Clin Invest (2009) 1.01
Fibroblast growth factor 23 acts on the parathyroid to decrease parathyroid hormone secretion. Curr Opin Nephrol Hypertens (2008) 0.95
A form of Jansen's metaphyseal chondrodysplasia with limited metabolic and skeletal abnormalities is caused by a novel activating parathyroid hormone (PTH)/PTH-related peptide receptor mutation. J Clin Endocrinol Metab (2004) 0.94
Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology. Am J Physiol Renal Physiol (2009) 0.90
The protein phosphatase calcineurin determines basal parathyroid hormone gene expression. Mol Endocrinol (2004) 0.90
Calcineurin Abeta is central to the expression of the renal type II Na/Pi co-transporter gene and to the regulation of renal phosphate transport. J Am Soc Nephrol (2004) 0.88
Identification and characterization of cis-acting elements in the human and bovine PTH mRNA 3'-untranslated region. J Bone Miner Res (2004) 0.84
Cis and trans acting factors in the regulation of parathyroid hormone (PTH) mRNA stability by calcium and phosphate. FEBS Lett (2002) 0.84
Human PTH gene regulation in vivo using transgenic mice. Am J Physiol Renal Physiol (2009) 0.83
Regulation of PTH mRNA stability by the calcimimetic R568 and the phosphorus binder lanthanum carbonate in CKD. Am J Physiol Renal Physiol (2009) 0.82
The parathyroid hormone mRNA 3'-untranslated region AU-rich element is an unstructured functional element. J Biol Chem (2003) 0.82
CKD-MBD: comfort in the trough of the U. Nephrol Dial Transplant (2011) 0.81
The calcium-sensing receptor regulates parathyroid hormone gene expression in transfected HEK293 cells. BMC Biol (2009) 0.81
Characterization of cis-acting element in renal NaPi-2 cotransporter mRNA that determines mRNA stability. Am J Physiol Renal Physiol (2002) 0.77
Mutational analysis of the PTH 3'-untranslated region in parathyroid disorders. Clin Endocrinol (Oxf) (2006) 0.76
Calcimimetics, vitamin D and ADVANCE in the management of CKD-MBD. Nephrol Dial Transplant (2011) 0.76
Micro-RNAs in the parathyroid: a new portal in understanding secondary hyperparathyroidism. Curr Opin Nephrol Hypertens (2016) 0.76
Vitamin D supplementation after renal transplantation: how much vitamin D should we prescribe? Kidney Int (2009) 0.75
Pathogenesis of parathyroid dysfunction in end-stage kidney disease. Pediatr Nephrol (2004) 0.75
Keeping divalent ions in their proper place. Curr Opin Nephrol Hypertens (2010) 0.75
Nutritional vitamin D: the benefits of supplementation. Curr Opin Nephrol Hypertens (2008) 0.75
Bone disease in chronic kidney disease: unraveling the details. Curr Opin Nephrol Hypertens (2009) 0.75